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Abstract 
Ohno's hypothesis postulates that upregulation of X-
linked genes rectifies their dosage imbalance relative 
to autosomal genes, which are present in two active 
copies per cell. Here we have dissected X-
chromosome upregulation into the kinetics of 
transcription, inferred from allele-specific single-cell 
RNA sequencing data from somatic and embryonic 
mouse cells. We confirmed increased X-chromosome 
expression levels in female and male cells and found 
that the X chromosome achieved upregulation by 
elevated burst frequencies. By monitoring 
transcriptional kinetics in differentiating female 
mouse embryonic stem cells, we found that increased 
burst frequency was established on the active X 
chromosome when X inactivation took place on the 
other allele. Thus, our study provides mechanistic 
insights into X-chromosome upregulation. 
Main 
In therian mammals, the X chromosome is present as 
two copies in female cells and one copy in male cells. 
This presents our cells with the challenge of balancing 
the X chromosome gene expression dose correctly for 
both females and males. If this molecular balance fails 
in one sex or the other, the products of genes located 
on chromosome X will be in disproportion relative to 
those of autosomes. The therian X and Y 
chromosomes evolved from an ancestral autosomal 
pair on which the genetic sex-determining 
factor Sry (ref. 1) appeared around 166–148 million 
years ago2. To preserve the genetic linkage 
between Sry and Y-linked male-beneficial genes Y–X 
recombination was repressed, leading to Y-
chromosome degeneration and gene loss over time3. 
This rendered males monosomic for X-linked genes 
and thus imbalanced with the diploid autosomal (A) 
part of the genome. Landmark theoretical work4 by 
Susumu Ohno proposed that cells restore the X:AA 
balance by doubling the expression of chromosome X, 
resulting in an X:AA expression ratio of 1 (analogous 
to the X:A ratio 2 when considering the expression of 
one allele). This concept (Fig. 1a) is termed Ohno's 
hypothesis, and the emergence of this compensatory 
process is presumed to predate the evolution of X-
chromosome inactivation5 (XCI), by which female 
cells silence one X chromosome to reach male-
equivalent expression levels for most X-linked genes. 
Several studies have reported X upregulation in 
mammals, initially using microarrays6,7,8,9 and later 
using RNA sequencing10, but the validity of Ohno's 
hypothesis has also been contested11,12,13,14, and a 
caveat to bulk analysis is that cellular heterogeneity 
may skew estimates of X upregulation due to cell 
subpopulations expressing chromosomes unequally. 
Emerging single cell RNA sequencing (scRNAseq) 
technology provides the opportunity to assess the X:A 
dose balance at the level of the actual regulatory 
system (that is, the cell), but dedicated scRNAseq 
studies are so far few13,15,16,17, and some arrived at 
opposite conclusions regarding X upregulation from 
comparable mouse scRNAseq data13,15. Moreover, a 
fundamental limitation in all present scRNAseq 
analyses is that they lack the unique molecular 
identifiers18 (UMIs) needed to avoid library 
amplification bias (which is particularly severe for 
scRNAseq cross-gene comparisons19) or lack the full-
length read coverage of transcripts needed for allele-
specific and single gene copy analyses. Finally, 
eukaryotic gene expression occurs through episodic 
bursting of RNA synthesis20,21,22,23, but kinetic studies 
of X upregulation are completely lacking. Here, we 
dissect X upregulation using transcriptional kinetics, 
providing mechanistic insights into this process. 
Results 
Elevated X-chromosome expression levels 
We investigated primary female fibroblasts (n = 224) 
and male embryonic stem cells (ESCs) cultured under 
2i+LIF condition (n = 188) from outbred mice 
(hybrids of CAST/EiJ and C57BL/6J) that were 
subjected to full length scRNAseq with 
UMIs22 (see Methods and Supplementary Fig. 1). We 
recently developed methods to infer transcriptional 
burst parameters individually for each gene 
copy22 using the two-state model of transcription24, 
providing allele-specific estimates of burst frequency 
(kon) and burst size (ksyn/koff) (Fig. 1b,c). To explore the 
kinetics of X upregulation, we first segregated female 
fibroblasts expressing either the maternal 
(CAST, n = 172) or paternal (C57, n = 52) X 
chromosome due to random XCI (Fig. 2 and 
Supplementary Fig. 2a–c). As expected, male ESCs 
(n = 188) transcribed exclusively the maternal X allele 
(Fig. 2b,c). To investigate chromosomal expression 
levels per cell and allele in an unbiased manner, we 
first counted all mRNAs detected (that is, at least one 
UMI) in the individual cells and calculated cellular 
expression levels for genes on the active X (Xa) and 
autosomal chromosomes. Strikingly, the average 
cellular X-chromosome RNA levels were higher than 
those of autosomal chromosomes in the same cells 
(P ≤ 3.8 × 10−10, paired Wilcoxon rank-sum test) 
(Fig. 3a). To avoid potential biases in preferential 
mapping of sequence reads towards one or the other 
genotype, we performed all comparisons between the 
allele of the active X chromosome with the 
corresponding parental allele for autosomal genes in 
each set of cells. On the other hand, no general strain-
related mapping bias was noted (Fig. 2b,c) and the 
results were consistent also when comparing the active 
X chromosome with autosomal genes of the opposite 
parental allele (Supplementary Fig. 2d–f). To avoid 
possible confoundment of a few highly expressed 
genes dominating the chromosomal expression 
estimates, we excluded genes beyond the 95th 
percentile of expression levels per cell. Other 
thresholds, such as the 90th and 99th percentile, 
provided similar results (Fig. 3b) and the X:A 
difference was significant across a wide span of 
thresholds (Fig. 3c). Next, to investigate the degree of 
X upregulation, we determined the gene-wise 
expression-level distributions for chromosome X 
(n = 149 genes, fibroblast C57 allele) and autosomes 
(n = 3,790 genes, fibroblast C57 allele), including only 
expressed genes (average ≥ 1 UMI detected per cell) 
that also had robustly inferable kinetic parameters 
(see Methods and Supplementary Fig. 3). This 
revealed a positively shifted expression level 
distribution for X-linked genes (median fold change of 
1.4, P = 4.2 × 10−5, two-sided Wilcoxon test; 
fibroblast C57 allele) (Fig. 3d,e). Comparing the 
distributions for all chromosomes, we observed such a 
shift to be unique for chromosome X (Fig. 3f,g). This 
was replicated on the fibroblast CAST allele and in 
male ESCs (Supplementary Figs. 4–6). We also 
calculated the median X:AA expression ratios, 
pooling the C57- and CAST-derived reads in cells, 
resulting in the ratios 0.80 and 0.76 (95% confidence 
intervals: 0.65–1.04 and 0.64–0.92, respectively) in 
female fibroblasts and male ESCs, respectively 
(Supplementary Fig. 7a). These results are in keeping 
with Ohno's hypothesis in terms of a distinct positive 
shift in the expression level distribution of X-linked 
genes in murine cells. At the same time, the data also 
suggest that a fully compensated 2:1 X:A expression 
ratio was not achieved, possibly due to only partial 
upregulation for some X genes or because not all genes 
undergo upregulation, in line with the notion that all 
genes are not equally dosage sensitive11,25. 
Transcriptional kinetics of X-chromosome 
upregulation 
We next investigated by what kinetic modulus of 
transcriptional regulation cells achieve upregulation of 
X-chromosome RNA levels. In the two-state model of 
transcription, expression levels are determined by (1) 
the fraction of time the gene spends in the 
transcriptional on state, generating a burst of RNA 
copies; (2) the average number of RNA molecules 
synthesized during such a burst; (3) the degradation 
rate of RNA (Fig. 1b,c). We compared burst 
frequencies (kon) for chromosome X and autosomes. 
Intriguingly, X-chromosome genes maintained 
distinctly elevated burst frequencies (median fold 
change of 1.5, P = 3.3 × 10−7, Wilcoxon test, fibroblast 
C57 allele, Fig. 4a–d). This was validated over the 
fibroblasts CAST allele as well as in male ESCs 
(P = 3.7 × 10−6 and 1.1 × 10−7, respectively) 
(Supplementary Figs. 5 and 6). Next, we performed 
similar analyses for burst sizes (ksyn/koff) and observed 
a lack of significant difference between chromosome 
X and autosomes (P = 0.93; power, 99%; Fig. 4e–
h and Supplementary Figs. 5–7). To confirm that these 
kinetic features were not unique for fibroblast- or 
ESC-specific transcripts, we repeated the analyses 
using housekeeping genes (see Methods and 
Supplementary Fig. 8). 
Previous studies26,27 found that X-chromosome 
transcripts tended to have longer RNA half-lives than 
those of autosomes, suggesting that lowered decay 
rates contribute to dosage compensation. We used 
metabolic-RNA-labelling data from mouse ESCs 
(see Methods) and investigated RNA decay rates for 
X-linked and autosomal genes. This indeed confirmed 
lowered decay rates for X-chromosome transcripts 
(P = 0.0059, Fig. 4i). However, we also observed the 
general trend that expression levels negatively 
correlated with decay rates independently of the 
chromosomal origin of RNAs (Spearman correlation 
of −0.38 and −0.35; P = 9.9 × 10−5 and P = 1.0 × 10−79 
for X and autosomal genes, respectively; Fig. 4i). We 
tested whether X genes had lowered decay rates given 
their expression levels by calculating the distribution 
of decay rates for autosomal genes of the same 
expression levels. X-chromosome genes and matched 
autosomal genes had similar decay rates (medians of 
0.15 and 0.15, P = 0.50, paired Wilcoxon test) 
(Fig. 4i). This is not in conflict with the fact that 
increased RNA stability might contribute to dosage 
compensation, but does motivate the search for X-
specific regulatory features. We reasoned that if 
increased burst frequency is a key mechanism to 
achieve X upregulation, a shifted burst frequency 
distribution might be detectable even when compared 
to autosomal genes of matched expression levels, 
albeit expectedly with a smaller shift because the 
autosomal expression distribution would artificially be 
shifted to higher values. Indeed, this was valid for both 
fibroblast alleles as well as for ESCs (P = 0.039, 
7.6 × 10−5 and 1.9 × 10−4, respectively; paired one-
sided Wilcoxon test) (Fig. 4j). 
In summary, our results imply that X-chromosome 
upregulation occurs through an increased frequency of 
transcriptional bursting in both female and male 
mouse cells. 
Increased X-chromosome burst frequencies 
establish as X inactivation takes place 
The widely accepted role of X inactivation is to avoid 
overdosing of X-linked gene products in female 
transcriptomes28,29 (Fig. 1a), which would otherwise 
be the result in cells carrying two hyperactive X-
chromosome copies. Female ESCs are generally 
devoid of XCI and contain two active X chromosomes, 
but XCI takes place as such cells are differentiated30,31. 
We aimed to use female ESCs to test whether elevated 
burst frequency is a constant property of chromosome 
X or whether it might establish in synchrony with XCI. 
To this end, we employed Smart-seq2 
data30 previously generated from female and male 
ESCs (C57BL/6J × CAST/EiJ hybrids) that were 
further differentiated into epiblast stem cells (EpiSCs) 
and post-mitotic neurons. These libraries lack UMIs, 
resulting in noisy estimates of burst sizes and the 
average number of molecules per cell22, because both 
these parameters are reliant on precise molecular 
counts. Nevertheless, burst frequency correlates 
strongly with the fraction of cells in which a gene is 
detected, and can be robustly inferred from Smart-
seq2 data due to the high sensitivity of this method. 
We first inspected chromosomal burst frequency 
distributions in female fibroblast Smart-seq2 data 
(hybrids of CAST/EiJ and C57BL/6J) (see Methods), 
validating the capability to detect elevated burst 
frequency for chromosome X by Smart-seq2 data 
(P = 1.1 × 10−3 and 4.8 × 10−4, two-sided Wilcoxon 
test, ncells = 78 and 212, Supplementary Fig. 9a–d). We 
then investigated burst frequencies in ESCs, EpiSCs 
and neurons of each sex. Female cells were further 
subgrouped according to their degree of allelic X-
chromosome expression bias (that is, the degree of 
XCI) (Fig. 5a), and for cells with XCI we monitored 
burst frequencies on the active X chromosome (that is, 
the allele with the highest expression in each cell). As 
expected, we recorded consistently significant 
increased burst frequencies for chromosome X in all 
tested cell types of male sex (P ≤ 5.0 × 10−9, two-sided 
Wilcoxon test) (Fig. 5b). Interestingly, however, 
female ESCs and ‘delayed’ EpiSCs that had not yet 
initiated XCI showed no sign of increased X 
chromosome burst frequencies (fraction Xa 
expression of 0.4–0.6, P = 0.26 and 0.65, two-sided 
Wilcoxon test) (Fig. 5a,b). EpiSCs with ongoing but 
not yet fully established XCI showed a mildly 
significant increase in X chromosome burst 
frequencies (fraction Xa expression of 0.6–
0.9, P = 0.033, two-sided Wilcoxon test) (Fig. 5a,b). 
Strikingly, female EpiSCs and neurons with 
completed XCI (fraction Xa expression ≥0.9) had 
positively shifted X burst frequency distributions 
(P = 3.8 × 10−5 and 6.1 × 10−7, respectively; two-sided 
Wilcoxon test) that were on par with those of male 
cells of the same cell type (P = 0.60 and 0.80, 
respectively) (Fig. 5a,b, functional enrichment of 
hyperactivated genes in Supplementary Table 1 and 
Supplementary Fig. 9e). 
Some genes possess the intrinsic ability to escape 
XCI32,33, but it is well established that their expression 
levels from the inactive X chromosome (Xi) tend to be 
lower than those from the same genes on the Xa. The 
allele-specific female fibroblasts data with UMIs 
allowed us to probe the transcriptional kinetics of 
escapee genes. We identified seven genes with 
inferable kinetics that escaped XCI in the female 
fibroblasts, in both XaCAST:XiC57 and 
XaC57:XiCAST cells (Supplementary Table 2; 
see Methods). We then calculated Xa- and Xi-specific 
burst frequencies and found that burst frequencies of 
escapee genes tended to be lowered on the Xi relative 
to the Xa allele (P = 0.0063 and 0.77 for burst 
frequency and size, respectively; binomial test) 
(Supplementary Fig. 9f). 
Altogether, these results imply that upregulation of 
burst frequencies on chromosome X is a plastic rather 
than constitutive property, and that burst frequencies 
are increased on the active X allele as differentiation 
and XCI take place in female cells (Fig. 5c). 
Discussion 
We have investigated X-chromosome upregulation at 
the resolution of transcriptional kinetics. Using 
scRNA-seq data with both full-transcript coverage and 
UMIs, we simultaneously obtained precise estimates 
of expression levels and detailed allele-specific 
information for single gene copy inferences. 
Analyzing these novel data, we confirmed the validity 
of Ohno's hypothesis by detecting positively shifted 
expression-level distributions for chromosome X both 
at the cellular and gene-wise levels (Fig. 3). The 
observed ~1.4-fold change in X:A levels (Fig. 3d) 
rather than a two-fold change suggests that not all X-
linked genes attained dosage compensation, or that 
less than two-fold upregulation is adequate to achieve 
sufficient X:A balance for some genes. Although XCI 
has been extensively explored, providing profound 
insights into gene silencing, mechanistic correlates to 
mammalian X upregulation are few16,26,27,34. By 
breaking down expression levels into kinetic 
parameters of transcription, we showed that dosage 
compensation is globally achieved via increased burst 
frequencies on chromosome X (Fig. 4). Furthermore, 
by monitoring burst frequency in differentiating ESCs, 
we found that female cells with two active X 
chromosomes (ESCs and ‘delayed’ EpiSCs) lacked 
increased burst frequency, and that this established on 
the active allele as XCI took place on the other allele 
(Fig. 5). These important findings indicate the 
existence of a molecular switch that can turn on (and 
off) the ‘X-chromosome hyperpulsation’ of gene 
expression. Identifying the exact molecular 
components involved in this burst-regulating switch 
will probably be a next milestone to fully understand, 
and possibly learn how to artificially manipulate, X-
chromosome dose regulation. Notably, impairment of 
this switch during early development would lead to X 
gene imbalance in the cells’ transcriptional network, 
probably resulting in developmental failure. Active X-
linked genes have previously been shown to be 
enriched in histone marks (H4K16ac and H3K4me3) 
and Pol II occupancy relative to autosomal genes26,34. 
Furthermore, RNAi knockdown of the acyltransferase 
males absent on the first (MOF), responsible for 
acetylating histone H4 at lysine 16, was shown to 
affect X-linked gene expression26. scRNA-seq with 
UMIs performed on cells with manipulated chromatin 
states might resolve whether MOF or other factors 
affects X-chromosome burst frequencies. Given that 
burst frequencies are preferentially encoded in 
enhancer elements22,35,36, it is likely that the increased 
transcriptional output from the X chromosome is due 
to one or more trans-acting factor affecting enhancers. 
Moreover, such factors would preferentially target 
enhancers located on the X chromosome. 
Methods 
Derivation and culturing of cell lines 
Primary mouse fibroblasts were derived from adult 
CAST/EiJ × C57BL/6J mice. Derivation was 
performed by skinning, mincing and culturing tail 
explants in fibroblast medium (DMEM high glucose 
(Invitrogen 41965-039), 10% ESC FBS (Gibco 
16141-079), 1% penicillin/streptomycin (Invitrogen 
15140-114), 1% non-essential amino acids (Invitrogen 
11140-035, 1% sodium-pyruvate (Invitrogen 11360-
039), 0.1mM β-mercaptoethanol (Sigma)). After 
removal ofexplants, the culture was passaged twice to 
attain a pue fibroblast culture. Mouse ESCs (derived 
from C57BL/6J × CAST/EiJ embryonic day 4 
blastocysts, as described previously30) were cultured 
in 2i+LIF medium (40 ml DMEM high glucose (Life 
Technologies 41965-039), 7.5 ml FBS (Life 
Technologies 10500-065), 0.5 ml penicillin-
streptomycin (5,000 U ml−1; 15070-063), 0.5 ml L-
glutamine (200 mM; Life Technologies 25030-024), 
0.5 ml NEAA (100×; Life Technologies 11140-035), 
0.1 ml 2-mercaptoethanol (50 mM; Life Technologies 
11140-035), 5 µl PD0325901 (10 mM in DMSO; 
Sigma Aldrich PZ0162-25MG), 5 µl CHIR99021 
(30 mM in DMSO; Sigma Aldrich SML1046-25MG), 
5 µl LIF (107 U ml−1; Millipore ESG1107)). Cultures 
were dissociated into single-cell suspensions using 
TrypLE Express (Gibco 12604-013), diluted in PBS, 
and distributed by flow cytometry (FACS core facility, 
Karolinska Institutet) into 96-well plates containing 
lysis buffer (1 µM Smarter oligo-dT, 0.5 mM (each) 
dNTPs, 0.15% Triton-X100, 1.3 U recombinant 
RNase inhibitor (TaKaRa)). Fibroblast and ESCs were 
tested negative for mycoplasma by 4,6-diamidino-2-
phenylindole staining. Animal experiments, used for 
the derivation of primary cells, were performed in 
compliance with animal care guidelines and approved 
by the Swedish Board of Agriculture, Jordbruksverket 
(permit N343/12). 
Sequencing and classification of expressed X-
chromosome allele in each cell 
A modified version of Smartseq237,38 was used to 
sequence the transcriptomes of primary mouse tail 
fibroblasts (n = 224) and ESCs (n = 188), as described 
in Larsson and others22. In brief, we utilized a 
modified Smartseq2 strand-switch primer containing a 
UMI (6-base random sequence). After full-length 
cDNA amplification and subsequent tagmentation, the 
5′ fragments contain the UMIs, while read coverage is 
additionally recorded along most of the transcript body 
(Supplementary Fig. 1). We used the UMIs to count 
molecules, and reads spanning single nucleotide 
polymorphism (SNPs) to determine the fraction 
expression from each allele. Sequencing was 
performed on an Illumina Nextseq 500, sequence 
reads were mapped to the C57 and CAST genomes, 
and reads spanning strain-specific SNPs were counted 
as described previously22,32,39. The sequencing data are 
available at the European Nucleotide Archive (E-
MTAB-7098). To classify cells as either having the 
C57 or the CAST X chromosome active in female 
fibroblasts, due to X inactivation, we calculated the 
aggregated expression of all genes and alleles on the 
X chromosome and compared the sums. The parental 
X chromosome with the higher sum was classified as 
having that allele active. In addition, we calculated the 
fraction of maternal RNA as shown in Fig. 2b to 
further verify this classification. All male ESCs 
expressed only the maternal X chromosome, as these 
cells carry only one X chromosome copy. 
Inference of transcriptional kinetics parameters 
In the model of transcription used, a gene switches to 
the on state and off state at exponentially distributed 
times with rates kon and koff, respectively. When the 
gene is on, RNA is produced at rate ksyn. Regardless of 
gene state, the RNA is degraded with rate λ. In brief, 
the probability distribution for the steady state of the 
stochastic process illustrated in Fig. 1b is the beta-
Poisson compound probability distribution. The 
parameters of this process were estimated in the 
timescale of degradation (λ) by maximum likelihood. 
Detailed information regarding the inference 
procedure is described in ref. 22. For cells in which the 
C57 X-chromosome allele was active, we inferred the 
parameter for autosomal genes at the C57 allele in the 
same cells (n fibroblasts C57 = 52; n ESCs 
C57 = 188). For cells in which the CAST X-
chromosome allele was active, we inferred the 
parameter for autosomal genes at the CAST allele in 
the same cells (n cells fibroblast CAST = 172). RNA 
decay rates were obtained for mouse ECSs from 
supplementary table 1 of ref. 40. 
Comparisons between chromosomes 
In all comparisons, we included genes that were 
expressed (≥1 UMI) in the given cells and that also had 
robustly inferable kinetic parameters (defined as 
within the bounds of the maximum likelihood 
procedure (10−3 < kon,koff < 103 and 1 < ksyn < 104) and 
biologically feasible (ksyn/koff > 1)). For the cell-wise 
analysis of chromosome expression levels (Fig. 3a) we 
included genes that were detected (at least 1 UMI) in 
each individual cell and excluded genes beyond the 
95th percentile of expression levels per cell. We 
calculated the mean expression level (E) for each 
chromosome (j; chr1–19, X) in each individual cell (k) 
and divided these values (Ej,k) by the mean expression 
of all autosomal genes (chr1–19) in the individual cells 
(Nk), resulting in normalized cellular values of 
chromosome mean expression, Yj,k = Ej,k/Nk, where j is 
the jth chromosome in cell k. This normalization 
functions to center the overall mean autosomal 
expression at 1 to facilitate X:A comparisons in 
Fig. 3a and does not affect the P values of the paired 
X:A comparisons, because chrX and autosomal values 
are normalized by the same value within each cell. We 
repeated the analysis using different upper expression 
thresholds, and cellular X:A differences were 
significant even when excluding as much as the upper 
50% of genes (Fig. 3c). Median X:AA ratios 
(Supplementary Fig. 7a) were estimated by 
calculating the mean total expression of all expressed 
genes (that is, expression from both C57 and CAST) 
and calculating the ratio of median X-linked and 
autosomal genes, and 95% confidence intervals were 
estimated by bootstrapping with replacement. To 
compare gene-wise expression levels between 
chromosome X and autosomes, we calculated the 
mean expression for each gene across the cells of a 
given cell type and genotype (C57 allele in cells 
having the C57 X chromosome active; CAST allele in 
cells having the CAST X chromosome active) and 
plotted a smoothed kernel density. To assess the 
probability of drawing a set of genes with a median 
equal to or higher than that of X-linked genes from the 
autosomal distribution, we randomly subsampled 
autosomal genes (n = n[X-linked genes]; for example, 149 in 
the case of the fibroblast C57 allele) and calculated the 
median expression level. This was repeated 100,000 
times (Fig. 3e), and we calculated the fraction (f) of 
permutations for which the median of the random 
autosomal subset equated or exceeded the median of 
chromosome X. Corresponding analyses were 
performed for burst frequency (kon) and burst size 
(ksyn/koff). To assess the differences between 
chromosomes in mean expression (UMIs per cell), 
burst frequency and burst size, we used the Wilcoxon 
rank-sum test as specified in the figure legends for 
each comparison. Housekeeping genes used in 
Supplementary Fig. 8 were ubiquitously expressed 
genes41 (genes expressed across 17 mouse tissues). 
Power analysis of detecting X-chromosome wide 
upregulation in burst size 
To assess whether we would have the power to detect 
a 1.4× change in expression level due to burst size, we 
randomly selected 149 autosomal genes, increased 
their burst size by 1.4, used the Wilcoxon rank-sum 
test and noted the P value of this test. This was 
repeated 1,000 times. 
Burst frequency analysis of female fibroblast Smart-
seq2 data 
We used Smart-seq2 data (ArrayExpress: E-MTAB-
6385) from female mouse fibroblasts (hybrids of 
CAST/EiJ and C57BL/6J) and inferred burst 
frequencies as described in a previous section. 
Burst frequency analysis of differentiating ESCs 
We inferred burst frequencies as described in a 
previous section using Smart-seq2 data30 (GEO 
accession no. GSE74155). Grouping of female cells 
into categories based on XCI status was done as 
follows: the allele-specific reads in each cell were 
summed over all X-linked genes for the CAST and 
C57 alleles. The fraction of reads mapping to C57 and 
CAST was then calculated (for example, 
fractionC57 = readsC57/(readsC57 + readsCAST)) for each 
cell. We only considered cells with XCI toward the 
C57 allele, because most cells were of the Xa:CAST 
status due to the genetic predisposition for silencing 
the C57 X chromosome in this cross breed39,42 and cell 
numbers of the reverse parental XCI status were 
insufficient for further analysis30. Female cells of 
each cell type were subgrouped according to their 
inferred XCI status: (1) ‘XaXa’, both X alleles active 
(0.4–0.6 fraction XCAST reads); (2) ‘XaXs’, semi-
inactivated X or ongoing XCI (0.6–0.9 fraction 
XCAST reads); (3) ‘XaXi’, completed XCI (≥0.9 
fraction XCAST reads) (Fig. 5a). For male cells, we 
analyzed the maternal X allele. We inferred the burst 
kinetics parameter for the CAST allele of all 
autosomal and X-linked genes based on the cells in the 
given category. To plot burst frequencies of the 
various cell types in Fig. 5b on the same scale (same 
median value of the autosomal null distributions), we 
normalized all values to the median burst frequency of 
autosomal genes in each category. P values for the 
X:A comparisons of burst frequencies were calculated 
using two-sided Wilcoxon tests (rank-based and thus 
unaffected by the median normalization). 
Functional enrichment analysis 
We identified genes with increased burst frequency 
upon X upregulation in the Smart-seq2 ESC and 
EpiSC data used in Fig. 5. To do this, we calculated 
the fold change in burst frequency between the 
following conditions: (1) female EpiSCs cells with full 
XCI compared to female EpiSCs devoid of XCI, (2) 
male EpiSCs compared to female EpiSCs devoid of 
XCI, (3) male ESCs compared to female ESCs devoid 
of XCI. This resulted in three gene sets. Genes with a 
positive fold change of over 1.1 were used for 
enrichment analysis. The overlap of the three sets was 
high (Supplementary Fig. 9e). We then tested the 
enrichment of gene ontology terms and transcription 
factor motifs of genes (1 kb upstream and downstream 
of the transcription start site, from TRANSFAC) in 
three gene sets using gProfiler43, with an order query 
(meaning that genes contribute to the enrichment 
according to their relative upregulation), and the 
background gene set of all annotated genes 
(Supplementary Table 1). 
Identification and analysis of genes escaping XCI 
To identify genes that escaped XCI in female 
fibroblasts we counted detection events from Xi for 
female fibroblasts of both XaCAST:XiC57 and 
XaC57:XiCAST XCI status. To avoid listing spuriously 
escaping genes, we considered only genes that were 
detected from Xi in at least 10% frequency relative to 
that of Xa and escaped in both XaCAST:XiC57 and 
XaC57:XiCAST cells, and we used the threshold of least 
two UMIs to call a detection even in this analysis to 
avoid false positive detection due to PCR errors, which 
generally results in not more than one unique UMI. 
We considered only genes with inferable kinetics (see 
parameter space in Supplementary Fig. 3). This 
resulted in the identification of seven escapee genes 
(~5% of genes with inferable kinetics—Xist, Ddx3x, 
Kdm6a, Kdm6c, Utp14a, 5530601H04Rik, Cox7b), 
out of which all except Cox7b were previously known 
escapees. To assess differences in transcriptional burst 
kinetics between the escapee gene allele on Xi and Xa, 
we inferred the kinetic parameters from the inactivated 
allele in both conditions (XiC57 and XiCAST) 
(Supplementary Table 2). We then calculated the fold 
change in burst frequency and size from the inactive 
relative to the active allele (Xi/Xa). To test whether 
there was a systematic drift in these Xi/Xa fold 
changes, we used a binomial test with the null 
hypothesis that a fold change above 1 is as likely as a 
fold change below 1. Xist was excluded in this 
analysis, because Xist is a chromatin-bound RNA and 
is exclusively expressed from Xi (Fig. 2c). 
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Fig. 1: Investigating X-chromosome upregulation by transcriptional kinetics. a, Ohno's hypothesis postulates that the relative levels 
of gene dosage between autosomal and X-linked genes have been restored by chromosome-wide upregulation of X-linked genes. XCI 
occurs in female cells to avoid overdosing of X gene products. b, Left: schematic depicting the stochastic process used to model 
transcriptional bursting in this study. Genes fluctuate between an idle off state and active on state, during which a burst of RNA molecules 
is generated. The waiting times in switching between the off and on states are determined by 1/kon and 1/koff, respectively. The average 
number of RNA copies produced per burst episode is ksyn/koff, and RNA is removed from the cell at degradation rate λ. Right: 
transcriptional bursting results in fluctuations in the levels of cellular RNA over time. The time the gene is on or off is colored in green 
or red, respectively. c, Left: burst frequency (kon) and burst size (ksyn/koff) inferred in genes on the C57 allele in mouse female fibroblasts 
expressing the C57 X chromosome, colored by expression level (n = 6,579 genes). Right: burst frequency (top) and size (bottom) both 
determine the expression level of genes (20 bins, 329 genes per bin). Center lines denote the median, hinges denote the interquartile 





Fig. 2: Classification of cells based on X inactivation status. a, The types, sexes, genotypes and numbers of mouse cells analyzed in 
this study. b, Segregation of cells based on expressing either the maternal or paternal X chromosome due to XCI in female cells. Each 
dot represents a cell, and the fraction of RNA molecules originating from the maternal allele (x axis) is shown for chromosome X (red) 
and autosomes (blue). White dots represent the median values for autosomal and X-chromosome genes for each set of cells. c, 
Relationship between the mean gene expression level from the CAST and C57 alleles. Left: data from female fibroblasts, separated based 
on Xa status (Xa:C57 top; Xa:CAST bottom), and with X-inactive specific transcript (Xist) highlighted. Right: data from male ESCs. 











Fig. 3: Elevated expression levels of X-linked genes.  a, Cellular mean expression level per chromosome, normalized by mean 
expression of all autosomal genes within each individual cell and allele, shown as boxplots with each data point representing a cell. 
Genes beyond the 95th percentile in expression level are excluded. Center lines denote the median, hinges denote the IQR and whiskers 
denote outlier points at maximum 1.5× IQR. Paired Wilcoxon rank-sum test (mean X versus autosomal in cells) used for significance 
testing. b,c, Median of normalized cellular expression levels for chromosome X (red) and autosomes (light blue) (b) and P values (paired 
Wilcoxon rank-sum test) (c), shown for different upper thresholds and corresponding to the data and same number of cells as shown 
in a. d, Distribution of the expression levels of autosomal and X-linked genes on the C57 allele in female fibroblasts with the C57 X-
allele active. Wilcoxon rank-sum test used for significance testing. e, Histogram of median expression levels of randomly subsampled 
autosomal genes compared to the median of X-linked genes (n = 149 genes; 100,000 permutations), where f is the fraction of permutations 
for which the autosomal median reached that of chromosome X. f, Distribution of expression levels for genes on each autosomal 
chromosome (light blue, 93–325 genes), all autosomes (dark blue, 3,790 genes) and chromosome X (red, 149 genes). Center lines denote 
the median, hinges denote the IQR and whiskers denote outlier points at a maximum 1.5 × IQR. The dashed red line indicate the X-
chromosome median. One-sided Wilcoxon rank-sum test was used for significance testing. g, Heatmap of P values from all pairwise 












Fig. 4: Transcriptional kinetics of X-chromosome upregulation. a, Distribution of burst frequency (kon) of autosomal and X-linked 
genes on the C57 allele in female fibroblasts with the C57 X allele active. Wilcoxon rank-sum test used for significance testing. b, Median 
burst frequency of random subsets of autosomal genes compared to that of X-linked genes (n = 149 genes; 100,000 permutations), 
where f denotes the fraction of permutations for which the autosomal median reached that of chromosome X. c, Distribution of burst 
frequencies for each autosomal chromosome (light green), all autosomal genes (dark green) and chromosome X (red), shown as boxplots. 
Center lines denote the median, hinges denote the IQR and whiskers denote outlier points at maximum 1.5× IQR. The dashed red line 
indicate the X-chromosome median. One-sided Wilcoxon rank-sum test was used for significance testing. d, Heatmap of P values from 
all pairwise comparisons of burst frequency between chromosomes using two-sided Wilcoxon rank sum tests. e–h, Same as a–d but for 
burst size (ksyn/koff). i, Top left: boxplots showing distributions of RNA decay rates for autosomal, X-linked and expression-matched 
autosomal genes in the C57 allele in ESCs. Top right: scatterplot showing the correlation between RNA decay rate and mean expression 
level (2,690 autosomal and 99 X-linked genes, Spearman correlation) with regression lines for X and autosomal genes in red and black, 
respectively. Bottom: boxplots showing distributions of expression levels for autosomal, X-linked and expression-matched autosomal 
genes. Center lines denote the median, hinges denote the IQR and whiskers denote outlier points at a maximum 1.5× IQR. j, Distribution 
of burst frequency for X chromosome (red) and autosomal genes of matched (nearest) expression value (green), shown for each allele in 
fibroblasts and the C57 allele for ESCs. Dashed lines indicate the medians. Paired one-sided Wilcoxon rank-sum test was used for 










Fig. 5: X-chromosome burst frequencies during differentiation of ESCs. Smart-seq2 data from female and male ESCs differentiated 
into EpiSCs and neurons. a, Allelic expression bias for chromosome X used to infer XCI status in female cells. Cells are grouped 
according to sex, cell type and XCI status: (1) ‘XaXa’, both X alleles active (0.4–0.6 fraction reads); (2) ‘XaXs’, semi-inactivated X or 
ongoing XCI (0.6–0.9 fraction reads); (3) ‘XaXi’, completed XCI (≥0.9 fraction reads). b, Distribution of burst frequencies for X-linked 
genes relative to the median burst frequency for autosomal genes for each sex, cell type and XCI state. Center lines denote the median, 
hinges denote the IQR and notches indicated the 95% confidence intervals of the median. P values were determined by two-sided 
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Supplementary Fig. 1 | Mapping features of sequence libraries from mouse primary fibroblasts and embryonic stem cells.
Single-cell RNA-seq libraries from mouse primary fibroblast: (a) Violin plot of number of sequence reads per cell. (b) Violin plot of 
number of unique molecular iden�fiers (UMIs) iden�fied per cell. (c) Violin plot of number of unique genes with UMIs detected 
per cell. (d) Frac�on of reads mapping to exons (blue), introns (orange) and intergenic regions (green). (e) Coverage of reads for 
eight representa�ve single-cell libraries along the gene body. This par�cular modified version of Smart-seq2 has a bias for the 5’ 
end of the transcript where the UMI is located. Single-cell RNA-seq libraries from mouse embryonic stem cells: (f-j) Same as (a-e) 
but for mouse embryonic stem cells.
Supplementary Fig. 2 | Allele-specific expression in soma�c cells from hybrid mice.
(a) Boxplots of allele-specific expression per chromosome and each data point being a cell, shown as the frac�on C57-mapping 
reads. Data from female fibroblasts having the C57 X chromosome as the ac�ve X. Centre lines denote the median, hinges denote 
the IQR, and whiskers denote 1.5×IQR. (b) Same as in (a) but for female fibroblasts having the CAST X chromosome as the ac�ve X. 
(c) Same as in (a) but for male embryonic stem cells carrying a maternal C57 X chromosome. (d) Boxplots of cellular mean 
expression level of detected genes on each chromosome normalized by mean expression of all autosomal genes within individual 
female fibroblasts having the C57 X chromosome as the ac�ve X copy, shown as boxplots. This is the same as shown in main Fig. 
3a, but also showing data for the CAST allele for comparison. The expression levels of genes expressed from the inac�ve CAST X 
chromosome represents the mean expression of escapee genes. (e) Similar as in (d) but for female fibroblasts having the CAST X 
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Supplementary Fig. 3 | Distribu�on of inferred kine�c parameters.
Sca�er plots of the burst frequency (kon) and size (ksyn/koff) derived for genes in single-cell libraries. Genes that passed the inference 
quality control (Methods) are colored according to mean expression level and genes that did not pass the inference quality control 
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Supplementary Fig. 4 | X-chromosome upregula�on by increased burst frequency.
Addi�onal data related to main Fig. 3-4 showing that expression level distribu�ons, burst frequency distribu�ons, and burst size 
distribu�ons were similar independent of whether recorded from the C57 or CAST alleles. (a-b) As in main Fig. 3d-e but also 
showing the autosomal expression for the CAST allele. Data from female fibroblasts having the C57 X chromosome as the ac�ve X 
copy. (c) The numbers and union of autosomal genes with inferable kine�cs and consistently expressed (mean UMI count ≥1) for 
the C57 and CAST allele. (d) As in main Fig. 3f but also showing the autosomal expression-levels for the CAST allele for comparison. 
(e) Burst frequency distribu�ons in female fibroblasts having the C57 X chromosome as the ac�ve X copy. As in main Fig. 4a, but 
also showing autosomal data from the CAST allele for comparison. (f) Burst size distribu�ons in female fibroblasts having the C57 X 
chromosome as the ac�ve X copy. As in main Fig. 4e, but also showing autosomal data from the CAST allele for comparison. (g) 
Histograms showing the frac�on cells in which the analyzed autosomal and X-linked genes with inferable kine�cs were detected in 
female fibroblasts and male embryonic stem cells. These data are related to main Fig. 4d-g, Fig. 4a-h, and Supplementary Fig. 5-6. 
Note that the increased frac�on cells with detected X-linked genes (red) compared to autosomal genes (blue) is consistent with an 
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Supplementary Fig. 5 | Analysis of the CAST allele in fibroblasts expressing the CAST X chromosome.
(a) Distribu�on of expression levels of autosomal and X-linked genes on the CAST allele in female fibroblasts carrying an ac�ve 
CAST X chromosome. Wilcoxon rank-sum test used for significance tes�ng. (b) Median expression levels of randomly selected 
subsets of autosomal genes compared to the X-linked genes (n=154 genes per permuta�on and 100,000 total permuta�ons), and f 
deno�ng frac�on permuta�ons for which the autosomal median reached that of chromosome X. (c) Distribu�on of expression 
levels for genes on each autosomal chromosome (light blue), all autosomes (dark blue), and chromosome X (red). Centre lines 
denote the median, hinges denote the IQR, and whiskers denote 1.5×IQR. One-sided Wilcoxon rank-sum test used for significance 
tes�ng. (d) Heatmap of P-values from pairwise comparison of expression level between chromosomes from the Wilcoxon rank 
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Supplementary Fig. 6 | Analysis of the C57 allele in male embryonic stem cells expressing a maternal C57 X chromosome.
(a) Distribu�on of expression levels of autosomal and X-linked genes on the C57 allele in male embryonic stem cells carrying a 
maternal C57 X chromosome. Wilcoxon rank-sum test used for significance tes�ng. (b) Median expression levels of randomly 
selected subsets of autosomal genes compared to the X-linked genes (n=125 genes per permuta�on and 100,000 total permuta-
�ons), and f deno�ng frac�on permuta�ons for which the autosomal median reached that of chromosome X. (c) Distribu�on of 
expression levels for genes on each autosomal chromosome (light blue), all autosomes (dark blue), and chromosome X (red).  
Centre lines denote the median, hinges denote the IQR, and whiskers denote 1.5×IQR. One-sided Wilcoxon rank-sum test used for 
significance tes�ng. (d) Heatmap of P-values from pairwise comparison of expression level between chromosomes from the 
















































Supplementary Fig. 7 | Median X:AA ra�os and power analysis of burst-size increase for X-linked genes.
(a) Median X:AA ra�os (dots) calculated by pooling C57- and CAST-derived reads in cells, shown for mouse fibroblasts and 
embryonic stem cells. The bars indicate the 95% confidence intervals of the medians. (b) Distribu�on of P-values from the 
Wilcoxon rank-sum test comparing the burst size (ksyn/koff) of autosomal genes on the C57 allele in fibroblasts to a simulated 
chromosome consis�ng of 149 randomly selected autosomal genes which have been upregulated in expression levels to 1.4x its 
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Supplementary Fig. 8 | Kine�cs of X-upregula�on for ubiquitously expressed genes.
(a) Cellular mean expression level of genes on each chromosome normalized by mean expression of ubiquitously expressed 
autosomal genes within each individual cell and allele, shown as boxplots. Genes beyond the 95th percen�le in expression level 
excluded. Centre lines denote the median, hinges denote the IQR, and whiskers denote outlier points at maximum 1.5×IQR. 
Wilcoxon rank-sum test used for significance tes�ng. (b-d) Distribu�on of (b) expression level, (c) burst frequency, and (d) burst 
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Supplementary Fig. 9 | Rela�ve burst frequencies and sizes on the inac�ve and ac�ve X chromosome for genes escaping 
X-inac�va�on. 
(a) Boxplots showing burst frequency distribu�ons of autosomal (red) and X-linked (blue) genes (n = 9,902 genes and 333 genes 
respec�vely) for female fibroblasts sequenced using Smart-seq2, in which the C57 allele was classified as Xa (n= 78 cells). P-value 
according to the two-sided Wilcoxon rank-sum test. (b) Heatmap of P-values from all pairwise comparisons of burst frequency 
distribu�ons between chromosomes using the two-sided Wilcoxon rank sum test. Data from female fibroblasts sequenced using 
Smart-seq2, in which the C57 allele was classified as Xa (n= 78 cells). (c-d) As in (a-b) but for female fibroblasts sequenced using 
Smart-seq2 in which the CAST allele was classified as Xa (n= 212 cells). (e) Venn diagram showing the number of overlapping genes 
in the three gene sets used in the func�onal enrichment analysis in Supplementary table 1. (f) Sca�er plot of the fold-change 
(log10) in burst frequency and size between the Xi and Xa alleles for genes iden�fied to escape XCI in both C57:Xa and CAST:Xa cells 
(Ddx3x, Kdm6a, Kdm6c, Utp14a, 5530601H04Rik, Cox7b). The burst kine�cs parameters inferred in C57:Xa and CAST:Xa cells are 
colored red and green, respec�vely.




















































TF Factor: Atf-1; motif: RTGACGTA; match class: 1 2,39
TF Factor: BTEB2; motif: GNAGGGGGNGGGSSNN; match class: 1 3,07 4,57
TF Factor: CREB,; motif: NTGACGTNA; match class: 1 1,31 4,50
TF Factor: CTCF; motif: NAGGGGGCGCNNKNNNN; match class: 1 2,03 4,25
TF Factor: E2F-1; motif: TTTSGCGCGMNR; match class: 0 1,58 2,82 4,00
TF Factor: E2F-1; motif: TWSGCGCGAAAAYKR; match class: 1 1,53 3,75
TF Factor: E2F-4; motif: NTTTCSCGCC; match class: 1 1,49 1,90 2,04 3,50
TF Factor: E2F; motif: GGCGSG; match class: 0 4,57 1,35 2,02 3,25
TF Factor: E2F; motif: NKCGCGCSAAAN; match class: 0 1,45 3,00
TF Factor: ELF4; motif: CCCGGAARTN; match class: 0 1,65 1,42 2,75
TF Factor: ELK-1; motif: ACCGGAWRTN; match class: 1 1,77 2,50
TF Factor: ER71; motif: ACCGGAARYN; match class: 0 1,77 2,25
TF Factor: ER81; motif: RCCGGAWRYN; match class: 0 1,53 2,00
TF Factor: ERF; motif: ACCGGAARTN; match class: 0 2,14 1,75
TF Factor: ESE-1; motif: NSMGGAARYN; match class: 0 1,71 1,50
TF Factor: Ehf; motif: NNNANCCGGAAGTNN; match class: 0 1,61 1,31
TF Factor: Erm; motif: NCCGGAWGTN; match class: 0 2,11
TF Factor: GABPalpha; motif: ACCGGAARYN; match class: 0 1,61 ns
TF Factor: GKLF; motif: NNRRGRRNGNSNNN; match class: 1 1,93 1,35
TF Factor: Kaiso; motif: GCMGGGRGCRGS; match class: 0 2,79
TF Factor: Klf17; motif: NGGGCGG; match class: 0 1,31
TF Factor: Pet-1; motif: ACCGGAARYN; match class: 0 1,50
TF Factor: SP100; motif: NNCGTCGNNTAAWNN; match class: 0 1,34
TF Factor: Sp2; motif: NYSGCCCCGCCCCCY; match class: 0 1,98
TF Factor: YY1; motif: NNNCGGCCATCTTGNCTSNW; match class: 1 1,53
TF Factor: YY1; motif: NYNKCCATNTT; match class: 1 1,31
TF Factor: ZF5; motif: GYCGCGCARNGCNN; match class: 0 1,30 1,89
TF Factor: Zfp740; motif: NCCCCCCCAC; match class: 1 1,71
TF Factor: Zfp740; motif: NNNCCCCCCCCMNNNN; match class: 1 2,29
GO:BP catabolic process 1,86
GO:BP cellular aromatic compound metabolic process 3,42 1,51
GO:BP cellular biogenic amine metabolic process 1,80 4,39
GO:BP cellular catabolic process 1,34 4,25
GO:BP cellular macromolecule catabolic process 2,21 4,00
GO:BP cellular metabolic process 1,52 2,94 2,10 3,75
GO:BP cellular nitrogen compound metabolic process 4,19 1,97 3,50
GO:BP cellular protein catabolic process 3,52 3,25
GO:BP cellular response to DNA damage stimulus 1,93 3,00
GO:BP chromatin organization 2,60 2,75
GO:BP chromosome organization 1,96 2,50
GO:BP covalent chromatin modification 2,79 2,25
GO:BP embryonic brain development 2,61 2,00
GO:BP gene expression 1,44 1,75
GO:BP heterocycle metabolic process 3,58 1,64 1,50
GO:BP histone modification 2,88 1,31
GO:BP macromolecule catabolic process 3,81 1,45
GO:BP modification-dependent macromolecule catabolic process 4,19 ns
GO:BP modification-dependent protein catabolic process 4,27
GO:BP negative regulation of RNA biosynthetic process 2,70
GO:BP negative regulation of RNA metabolic process 2,92
GO:BP negative regulation of biosynthetic process 2,91 1,71
GO:BP negative regulation of cellular biosynthetic process 3,10 1,89
GO:BP negative regulation of cellular macromolecule biosynthetic process 3,22 2,47
GO:BP negative regulation of cellular metabolic process 2,16
GO:BP negative regulation of cellular process 1,53
GO:BP negative regulation of gene expression 2,17
GO:BP negative regulation of macromolecule biosynthetic process 2,88 2,13
GO:BP negative regulation of macromolecule metabolic process 1,71
GO:BP negative regulation of nitrogen compound metabolic process 2,18
GO:BP negative regulation of nucleic acid-templated transcription 2,71
GO:BP negative regulation of nucleobase-containing compound metabolic process 2,45
GO:BP negative regulation of transcription by RNA polymerase II 3,09 1,31
GO:BP negative regulation of transcription, DNA-templated 2,91

















GO:BP nucleic acid metabolic process 2,14
GO:BP nucleobase-containing compound metabolic process 3,61
GO:BP organic cyclic compound metabolic process 3,67 1,79
GO:BP organic substance catabolic process 1,98
GO:BP organic substance metabolic process 1,76
GO:BP organonitrogen compound catabolic process 4,11 1,31
GO:BP organonitrogen compound metabolic process 2,49
GO:BP primary metabolic process 1,54
GO:BP proteasomal protein catabolic process 1,61
GO:BP proteasome-mediated ubiquitin-dependent protein catabolic process 1,53
GO:BP protein catabolic process 4,39 1,78 1,55
GO:BP proteolysis involved in cellular protein catabolic process 3,23
GO:BP regulation of proteasomal ubiquitin-dependent protein catabolic process 1,79
GO:BP regulation of protein catabolic process 1,34
GO:BP regulation of transcription by RNA polymerase II 2,33
GO:BP transcription by RNA polymerase II 2,59
GO:BP ubiquitin-dependent protein catabolic process 4,35
GO:CC Golgi apparatus part 1,61 8,07
GO:CC Golgi subcompartment 1,48 8,00
GO:CC catalytic complex 2,50 2,95 1,38 7,50
GO:CC cell body 1,72 7,00
GO:CC cytoplasmic part 5,33 4,01 5,77 6,50
GO:CC cytosol 6,14 1,50 1,99 6,00
GO:CC cytosolic large ribosomal subunit 2,18 5,50
GO:CC cytosolic ribosome 1,67 5,00
GO:CC intracellular membrane-bounded organelle 4,87 7,14 8,07 4,50
GO:CC intracellular non-membrane-bounded organelle 1,85 1,45 4,00
GO:CC intracellular organelle lumen 3,89 2,85 3,12 3,50
GO:CC intracellular organelle part 4,07 5,68 6,17 3,00
GO:CC large ribosomal subunit 1,47 2,50
GO:CC membrane-enclosed lumen 3,89 2,85 3,11 2,00
GO:CC neuron projection 1,62 1,50
GO:CC neuronal cell body 1,53 1,32
GO:CC non-membrane-bounded organelle 1,82 1,42
GO:CC nuclear lumen 4,37 3,38 3,28 ns
GO:CC nuclear part 3,71 3,52 3,36
GO:CC nuclear transcriptional repressor complex 1,32
GO:CC nucleolus 2,31
GO:CC nucleoplasm 4,42 2,04 1,76
GO:CC nucleoplasm part 1,64
GO:CC nucleus 6,32 3,95 3,73
GO:CC organelle lumen 3,89 2,85 3,11
GO:CC organelle part 3,28 4,82 5,45
GO:CC protein-containing complex 2,43 3,32
GO:CC smooth endoplasmic reticulum 2,56
GO:CC somatodendritic compartment 1,43
GO:CC trans-Golgi network 1,76
GO:CC transferase complex 2,94 1,33
GO:MF GDP-dissociation inhibitor activity 1,37
GO:MF N-acetyltransferase activity 2,16 2,70
GO:MF N-acyltransferase activity 1,69 2,50
GO:MF acetyltransferase activity 1,67 2,25
GO:MF chromatin binding 1,77 1,55 2,00
GO:MF peptide N-acetyltransferase activity 1,32 1,75
GO:MF ribonucleoprotein complex binding 2,70 1,50
GO:MF transferase activity, transferring acyl groups 2,13 1,32


















Supplementary Table 2 | Transcriptional burst kinetics for escapee genes on the active and inactive X chromosome.
)cf(01gol_sbiX_sbaX_sb)cf(01gol_fbiX_fbaX_fbaXeneG
5530601H04Rik C57 0,03070 0,08063 0,41927 18,70864 5,06422 -0,56753
Cox7b C57 0,99499 0,36992 -0,42971 47,32819 25,61089 -0,26670
Ddx3x C57 0,36392 0,08509 -0,63110 16,93672 35,49227 0,32130
Kdm5c C57 2,30095 0,85200 -0,43147 1,28102 2,13658 0,22217
Kdm6a C57 0,26821 0,16146 -0,22041 1,69563 0,96752 -0,24367
Utp14a C57 0,60637 0,87518 0,15936 2,44329 0,38184 -0,80610
Xist C57 NaN 0,67409 NaN NaN 12,58132 NaN
5530601H04Rik CAST 0,15852 0,13886 -0,05752 6,94057 2,23850 -0,49144
Cox7b CAST 1,22833 0,08718 -1,14891 26,52124 47,66921 0,25464
Ddx3x CAST 0,55757 0,20073 -0,44369 12,87386 23,93504 0,26933
Kdm5c CAST 0,86358 0,45420 -0,27906 1,98135 2,58400 0,11533
Kdm6a CAST 0,17787 0,13888 -0,10746 1,53608 1,65105 0,03135
Utp14a CAST 1,12943 0,44363 -0,40584 1,30781 0,72961 -0,25346
Xist CAST NaN 1,11958 NaN NaN 8,11338 NaN
Burst kinetics of 7 genes expressed from the inactive X-chromosome. Inference based on 52 and 172 female fibroblasts, Xa:C57 
and Xa:CAST respectively. Xa: Active X-chromosome; bf_Xa: Burst frequency inferred from Xa; bf_Xi: Burst frequency inferred 
from Xi; bf_log10(fc): Burst frequency fold-change (Xi/Xa), log10; bs_Xa: Burst size inferred from Xa; bf_Xi: Burst size inferred 
from Xi; bs_log10(fc): Burst size fold-change (Xi/Xa), log10.
